About Inger Therapeutics
Inger Therapeutics is a Healthcare company based in Chennai (India) founded in 2021 by Bala Yeshwanth Ram Vummidi. Suprabodies are developed as peptide-based therapeutics for research applications. Its Indian entity Inger Therapeutics Private Limited reported revenue of ₹60.4 Lakh. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.
Company details
Inger Therapeutics was established in 2021 in Chennai, India, within the biotechnology sector. Peptide-based ligands, termed Suprabodies, are created using innovative screening methods. These ligands are supplied to pharmaceutical companies, biotechnology organizations, and academic institutions to support ligand discovery for therapeutic and research purposes. Operations focus on addressing needs in drug development and scientific applications.
- Headquarters Chennai, India
- Founders Bala Yeshwanth Ram Vummidi
- SectorsHealthcare
- Email••••••••
- Website ingertx.com
- Social LinkedIn
- Legal Name Inger Therapeutics Private Limited
- Date of Incorporation 28 Oct, 2021
- Jurisdiction Tiruvallur, Tamil Nadu, India
- Annual Revenue₹60.4 Lakh
FY 2024 · +127% YoY
- Net Profit₹94,875
FY 2024 · 2% margin
- EBITDA₹94,875
FY 2024 · 2% margin
- Investors
Associated legal entities of Inger Therapeutics
Inger Therapeutics operates through Inger Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Inger Therapeutics Private Limited CIN U33119TN2021PTC147484 | Active | 28 Oct 2021 | Tiruvallur, Tamil Nadu | ₹0.6 Cr | 2 | View details |
Funding Insights of Inger Therapeutics
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Inger Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Inger Therapeutics
Inger Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include StartupTN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Potato farming, grain marketing, and equipment services in Maine. | 2021 | startuptn.in | Chennai, India |
Investor details for Inger Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Inger Therapeutics Private Limited (Inger Therapeutics)
Inger Therapeutics Private Limited is the primary company behind Inger Therapeutics. The board of Inger Therapeutics Private Limited currently have 2 directors; the longest-serving is Bala Yeshwanth Ram Vummidi, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bala Yeshwanth Ram Vummidi DIN 09379251 | Director | 28 Oct 2021 | 5 yrs | Inger Therapeutics Private Limited |
| Surekha Vummidi DIN 09379252 | Director | 28 Oct 2021 | 5 yrs | Inger Therapeutics Private Limited |
People of Inger Therapeutics
1 people are tracked at Inger Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for Inger Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Inger Therapeutics
Figures of Inger Therapeutics Private Limited, the primary company behind Inger Therapeutics, for FY 2024. Revenue was ₹60.4 Lakh (+127% year on year). Net profit was ₹94,875 (2% margin). EBITDA was ₹94,875 (2% margin).
- ₹60.4 LakhRevenue · FY 2024 · +127% YoY
- ₹94,875Net profit · 2% margin
- ₹94,875EBITDA · 2% margin
- ₹2 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Inger Therapeutics Private Limited are on its company page.
Detailed financial statements for Inger Therapeutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Inger Therapeutics
2 dated milestones of Inger Therapeutics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Inger Therapeutics is founded.
- Funding First funding round.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Inger Therapeutics
Inger Therapeutics was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Inger Therapeutics is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
The primary company behind Inger Therapeutics, Inger Therapeutics Private Limited, reported revenue of ₹60.4 Lakh for FY 2024, up 127% year on year.
Inger Therapeutics was established in 2021 in Chennai, India, within the biotechnology sector. Peptide-based ligands, termed Suprabodies, are created using innovative screening methods. These ligands are supplied to pharmaceutical companies, biotechnology organizations, and academic institutions to support ligand discovery for therapeutic and research purposes. Operations focus on addressing needs in drug development and scientific applications.
Inger Therapeutics has 1 investor. Key investors include StartupTN.
Inger Therapeutics operates through Inger Therapeutics Private Limited.
The legal entities of Inger Therapeutics currently have 2 directors, including Bala Yeshwanth Ram Vummidi, Surekha Vummidi.